Dr. Sanuj K. Ravindran -Dr. Ravindran is the Managing Director of Asian Healthcare Fund (AHF), a New Delhi based PE/VC fund that invests in growth-stage healthcare and life sciences companies, primarily in India and Southeast Asia. Previously, Dr. Ravindran was a Principal of Radius Ventures, a venture capital firm focused on leading-edge health and life sciences companies; and prior to Radius, he was a Director of Burrill & Company’s venture capital group, where he also founded and led the Burrill India Group. In addition to his role with AHF, Dr. Ravindran currently serves on the Boards of Chennai based RxMD and Florida based Gyrx.
Dr. Ravindran’s prior board roles include Ambit Biosciences, Athersys, Resolvyx Pharmaceuticals, Endocyte, Proventys and diaDexus. He is a member of the Society of Kauffman Fellows and is a U.S. Board Certified physician (Internal Medicine). Dr. Ravindran received his B.A. from Northwestern University, his M.D. from Jefferson Medical College and his M.B.A. from the Kellogg School of Management, where he was a Rothschild Scholar.